Elmika 500mg Injection
Marketer
Elivia Life Sciences Pvt Ltd
Salt Composition
Amikacin (500mg)
Overview Elmika 500mg Injection
Cefazolin 500mg Injection is a broad-spectrum antibiotic combating diverse bacterial infections. These encompass urinary tract, bone, joint, lung (pneumonia), brain, and bloodstream infections. Prophylactic use is also indicated in hospitalized individuals to avert infections. Cefazolin 500mg Injection inhibits bacterial growth. Administered intravenously (IV infusion) or intramuscularly by a healthcare professional, self-injection is strictly prohibited. Adherence to the prescribed dosage schedule is crucial; incomplete treatment may result in relapse or infection exacerbation. Common adverse effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment ineffectiveness warrant medical consultation. High doses may cause vertigo, nephrotoxicity, and ototoxicity. Regular kidney function, hearing, and urine tests may be conducted during therapy. Pregnancy contraindicates this medication; disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Primary Ingredients of Elmika 500mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Elmika 500mg Injection
Infections caused by bacteria
Major Benefits of Elmika 500mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Elmika 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Elmika 500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Elmika 500mg Injection works:
The antibiotic injection Elmika 500mg inhibits bacterial proliferation by disrupting the production of vital proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from combining Elmika 500mg Injection with alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Elmika 500mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Elmika, 500mg, presents a low risk during lactation. Research in humans indicates minimal drug transfer to breast milk, posing no known threat to the infant.
DrivingUNSAFE
Administering Elmika 500mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving is prohibited should these effects manifest.
KidneyCAUTION
Caution is advised when administering Elmika 500mg Injection to individuals with impaired renal function. Dosage modification for Elmika 500mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Elmika 500mg Injection in individuals with hepatic impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Elmika 500mg Injection :
Should you forget a scheduled dose of Elmika 500mg Injection, seek medical advice.
Facts to Know About Elmika 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
3,018 People bought this recently